Epidemiology and Familial Risk of Synchronous and Metachronous Colorectal Cancer: A Population-Based Study in Utah

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 12, 2014, Pages 2078-2084.e2

  Samadder, N Jewel ^a,b   Curtin, Karen ^a,b   Wong, Jathine ^a   Tuohy, Thérèse M F ^a   Mineau, Geraldine P ^a,b   Smith, Ken Robert ^a   Pimentel, Richard ^a   Pappas, Lisa ^a   Boucher, Ken ^a   Garrido Laguna, Ignacio ^a,b   Provenzale, Dawn ^c,d   Burt, Randall W ^a,b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colon Cancer; Heritable; Prevention; Tumor

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASCENDING COLON; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER RISK; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METACHRONOUS COLORECTAL CANCER; MIDDLE AGED; PEDIGREE; POPULATION RESEARCH; PRACTICE GUIDELINE; SYNCHRONOUS COLORECTAL CANCER; UNITED STATES; COHORT ANALYSIS; COLORECTAL NEOPLASMS; FAMILY HEALTH; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PREVALENCE; RISK ASSESSMENT; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COLORECTAL NEOPLASMS; FAMILY HEALTH; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PREVALENCE; RISK ASSESSMENT; UTAH; YOUNG ADULT;

EID: 84918798155     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.04.017     Document Type: Article

References (24)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Burt R.W., Barthel J.S., Dunn K.B., et al. NCCN clinical practice guidelines in oncology. Colorectal cancer screening. JNatl Compr Canc Netw 2010, 8:8-61.
3. Rex D.K., Johnson D.A., Anderson J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 2009, 104:739-750. [corrected].
4. Jorde L.B. Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonomy, and migration matrices. Ann Hum Genet 1989, 53:339-355.
5. Warren S., Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 1932, 16:1358-1414.
6. Moertel C.G., Bargen J.A., Dockerty M.B. Multiple carcinomas of the large intestine: a review of the literature and a study of 261 cases. Gastroenterology 1958, 34:85-98.
7. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics 1977, 33:159-174.
8. Landis J.R., Koch G.G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977, 33:363-374.
9. Guthery S.L., Mineau G., Pimentel R., et al. Inflammatory bowel disease aggregation in Utah kindreds. Inflamm Bowel Dis 2011, 17:823-830.
10. Kerber R.A. Method for calculating risk associated with family history of a disease. Genet Epidemiol 1995, 12:291-301.
11. Hu H., Chang D.T., Nikiforova M.N., et al. Clinicopathologic features of synchronous colorectal carcinoma: a distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis. Am J Surg Pathol 2013, 37:1660-1670.
12. Pinol V., Andreu M., Castells A., et al. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors. Dis Colon Rectum 2004, 47:1192-1200.
13. Latournerie M., Jooste V., Cottet V., et al. Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg 2008, 95:1528-1533.
14. Passman M.A., Pommier R.F., Vetto J.T. Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum 1996, 39:329-334.
15. Mulder S.A., Kranse R., Damhuis R.A., et al. Prevalence and prognosis of synchronous colorectal cancer: a Dutch population-based study. Cancer Epidemiol 2011, 35:442-447.
16. Mulder S.A., Kranse R., Damhuis R.A., et al. The incidence and risk factors of metachronous colorectal cancer: an indication for follow-up. Dis Colon Rectum 2012, 55:522-531.
17. Cali R.L., Pitsch R.M., Thorson A.G., et al. Cumulative incidence of metachronous colorectal cancer. Dis Colon Rectum 1993, 36:388-393.
18. Fajobi O., Yiu C.Y., Sen-Gupta S.B., et al. Metachronous colorectal cancers. Br J Surg 1998, 85:897-901.
19. Leggett B.A., Cornwell M., Thomas L.R., et al. Characteristics of metachronous colorectal carcinoma occurring despite colonoscopic surveillance. Dis Colon Rectum 1997, 40:603-608.
20. Lam A.K., Gopalan V., Carmichael R., et al. Metachronous carcinomas in colorectum and its clinicopathological significance. Int J Colorectal Dis 2012, 27:1303-1310.
21. Lawes D.A., Pearson T., Sengupta S., et al. Is MSI-H of value in predicting the development of metachronous colorectal cancer?. Eur J Cancer 2006, 42:473-476.
22. Bae J.M., Cho N.Y., Kim T.Y., et al. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors. Dis Colon Rectum 2012, 55:181-190.
23. Nosho K., Kure S., Irahara N., et al. Aprospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. Gastroenterology 2009, 137:1609-1620. e1-3.
24. Lam A.K., Carmichael R., Gertraud Buettner P., et al. Clinicopathological significance of synchronous carcinoma in colorectal cancer. Am J Surg 2011, 202:39-44.